Manager, Clinical Contracts at Abata Therapeutics

San Diego, California, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Clinical TrialsIndustries

Requirements

  • Bachelor’s degree required
  • 5+ years’ experience in a contract management position within a biotechnology, pharmaceutical, academia or Clinical Research Organization (CRO)
  • Clinical Site Budget experience necessary
  • Experience within Global Oncology Phase 1-3 clinical trials preferred
  • Grant Plan experience a plus
  • Good knowledge of ICH-GCP, pharmaceutical related regulations and laws
  • Ability to thrive in a fast-paced growing company with minimal direction and ability to adjust to changing priorities
  • Proficiency in Microsoft Excel at an Intermediate level required
  • Strong analytical and contract administration skills
  • Strong verbal and written communication skills

Responsibilities

  • Provide comprehensive contract lifecycle management: Work closely with Clinical Operations, Legal, Finance, and other internal and external stakeholders to support the timely initiation, contractual term review, negotiation, risk assessment, execution and administration of contracts
  • Manage tracking of contracts, amendments and budgets, and provide updates to the project and cross-functional teams
  • Serve as point person for contracts with internal and external stakeholders
  • Support RFx and Vendor Management activities
  • Support internal oversight of site payment management
  • Establish contracting SOPs and guidance documents
  • Active participation in team meetings for the purpose of expediting contracts to execution
  • Build and maintain strong relationships with clinical sites and vendors
  • Facilitate contract actions and processes independently and effectively in a dynamic environment with competing priorities
  • Respond promptly and professionally to inquiries from internal team members and external vendors
  • Identify and implement process improvements to enhance efficiency and accountability
  • Ensure compliance with SOPs and regulatory guidelines, addressing QA and audit requests as needed

Skills

Key technologies and capabilities for this role

Contract NegotiationContract Lifecycle ManagementVendor ManagementBudget TrackingRisk AssessmentSOP DevelopmentCross-Functional CommunicationAnalytical SkillsProcess ImprovementRegulatory Compliance

Questions & Answers

Common questions about this position

What is the salary range for the Manager, Clinical Contracts position?

The base salary ranges from $130,000 to $155,000 annually, plus stock options, restricted stock units, a stock purchase plan (ESPP), and a target bonus.

What benefits are offered for this role?

Benefits include a comprehensive package with medical, dental, vision, and supplemental coverage for employees and their families, along with stock options, restricted stock units, ESPP, and a target bonus.

Is this position remote or does it require office work?

This information is not specified in the job description.

What experience and skills are required for this role?

Candidates need a Bachelor’s degree, 5+ years in contract management within biotech/pharma/academia/CRO, clinical site budget experience, good knowledge of ICH-GCP and regulations, ability to thrive in a fast-paced environment, and intermediate Microsoft Excel proficiency.

What makes a strong candidate for the Manager, Clinical Contracts role?

Ideal candidates have experience in Global Oncology Phase 1-3 trials (preferred), Grant Plan experience (a plus), strong analytical and communication skills, ability to work independently in a dynamic environment, and a track record of building relationships and implementing process improvements.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI